HIGHLIGHTS
- who: Polyethylene Glycol Loxenatide and colleagues from the University, China have published the research: Polyethylene Glycol Loxenatide Injection (GLP-1) Protects Vascular Endothelial Cell Function in Middle-Aged and Elderly Patients With Type 2 Diabetes by Regulating Gut Microbiota, in the Journal: (JOURNAL)
- what: In this study, a total of 36 stool samples and clinical data from 12 patients with T2DM were analyzed at W0, 4, and 8 during treatment with GLP-1. The authors found that the middle-aged and elderly diabetic patient population showed significant improvement in blood glucose lowering indices and inflammation . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.